Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

S Kraler, MC Blaser, E Aikawa, GG Camici… - European heart …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …

Molecular mechanisms of vascular health: insights from vascular aging and calcification

NR Sutton, R Malhotra, C St. Hilaire… - … , and vascular biology, 2023 - Am Heart Assoc
Cardiovascular disease is the most common cause of death worldwide, especially beyond
the age of 65 years, with the vast majority of morbidity and mortality due to myocardial …

NLRP3 inflammasome activation in peripheral arterial disease

F Bartoli‐Leonard, J Zimmer… - Journal of the …, 2023 - Am Heart Assoc
Background Peripheral arterial disease (PAD) is estimated to affect 7% of the adult
population in the United States; however, there is currently little understanding of the key …

Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?

W Broeders, S Bekkering, S El Messaoudi… - Basic Research in …, 2022 - Springer
Calcific aortic valve disease (CAVD) is the most common valvular disease in the developed
world with currently no effective pharmacological treatment available. CAVD results from a …

Valve-Adjustable Optofluidic Bio-Imaging Platform for Progressive Stenosis Investigation

L Chen, L Yu, Y Liu, H Xu, W Li, F Wang, J Zhu, K Yi… - ACS …, 2023 - ACS Publications
The clinical evidence has proven that valvular stenosis is closely related to many vascular
diseases, which attracts great academic attention to the corresponding pathological …

Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe

P Libby, Z Mallat, C Weyand - Cardiovascular research, 2021 - academic.oup.com
Practitioners have long recognized the involvement of inflammation in certain acute
cardiovascular diseases such as endocarditis, myocarditis, and pericarditis. Attention to the …

Therapeutic CCR2 blockade prevents inflammation and alleviates myxomatous valve disease in Marfan syndrome

N Xu, KE Yutzey - Basic to Translational Science, 2022 - jacc.org
Myxomatous valve disease (MVD) can lead to cardiac dysfunction and heart failure, yet
medical therapies are lacking. CC chemokine receptor type 2 (CCR2)+ immune cell …

Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling

N Poulis, M Martin, SP Hoerstrup… - Frontiers in …, 2022 - frontiersin.org
In situ heart valve tissue engineering approaches have been proposed as promising
strategies to overcome the limitations of current heart valve replacements. Tissue …

[HTML][HTML] The first taxonomic and functional characterization of human CAVD-associated microbiota

L Curini, B Alushi, MR Christopher, S Baldi… - Microbial Cell, 2023 - ncbi.nlm.nih.gov
Method: Calcified aortic valve (CAV) samples from twenty patients (11 from Germany and 9
from Italy) with diagnosis of severe symptomatic CAVD were used to assess the presence of …

Self-reported satisfaction to treatment, quality of life and general health of type 2 diabetes patients with inadequate glycemic control from north-eastern Romania

ED Grigorescu, CM Lăcătușu, I Crețu… - International Journal of …, 2021 - mdpi.com
Type 2 diabetes mellitus (T2DM) undermines health and quality of life (QoL). This cross-
sectional study surveyed 138 consenting T2DM patients from North-Eastern Romania with …